|
Second
Annual
R&D Strategies:
Managing Risk to Increase R&D Productivity
May
17-18, 2004
Philadelphia, PA
Register
Today
Download
Brochure
Plenary
Keynotes:
 |
Robert
R. Ruffolo, Ph.D.,
President, Research & Development,
Wyeth Pharmaceuticals;
Senior Vice President,
Wyeth Corporation |
 |
Jan-Anders
Karlsson, Ph.D.
Executive Vice President,
Pharma Research,
Bayer Healthcare AG
|
 |
Gianni
Gromo M.D.,
Head of Discovery Research
Basel, F.
Hoffmann-La Roche Ltd. |
Topics
to be Covered:
-
Creating an R&D
Model That
Best Positions
-
Your Organization to
Increase
Profitability
-
Implementing Strategies
to Improve
-
Quality of Your
Validated Targets
-
Going Beyond
Scenario-Based
Planning into Predictive Mode
-
Profiting from Discovery
and
Marketing Collaboration
-
Increasing
an Individual Scientist's
Productivity
Corporate Sponsors:



Lead
Sponsoring Publications:



R&D
Strategies is One of the Five Conferences
at
CHI's The World Pharmaceutical Congress- ID3
The Other Four Parts of The Congress are:
ADME/Tox:
From A to T
Cheminformatics:
Data Driving Decisions
Cell-based
Assays for HTS
Hit-to-Lead:Streamlining
Lead Generation
|
SPECIAL
FDA PRESENTATION
Orphan
Drug Designation to Encourage Innovation
Bradley Glasscock,
Pharm.D., Office of Orphan Products Development,
Food & Drug Administration |
Strategic
View of Risk Assessment
R&D
Productivity Enhancement Through Focus on Drugable Targets:
How to Differentiate ?
Daniel Schirlin,
Ph.D., Head of Global Lead Generation, Aventis
The Future of
Research Productivity and Innovation
Mark Seidler, Ph.D., Senior
Engagement Manager,
Strategic Decisions Group
Strategy,
Portfolio Management & Risk
Integrated Approach
to Portfolio Management: Linking Discovery to
the Market through Clinical Development
Rick Bayney,
Ph.D., Vice President, Portfolio Management, PRD,
Johnson & Johnson
Integrated
R&D/Commercial Cross-Functional Approaches
to Strategy, Portfolio and Risk
Ramana
Sonty, Senior Director/Team Leader, World Wide
Development, Pfizer Global Pharmaceuticals
R&D
Strategy and
Knowledge Management
Implementing
Strategies to Improve the Quality of
Your Validated Targets
Douglas
Axelrod, Ph.D., R&D Manager, Discovery and Early
Development, Proctor & Gamble
Improving collaboration and
decision making through
Knowledge Management
Harvey L. Wiener,
Ph.D., M.B.A., Associate Director,
Knowledge Integration Resources, Bristol-Myers Squibb Company
Managing Knowledge for the Business
of Science
Joseph A. Cerro,
Head of Informatics Research,
Bayer Pharmaceuticals Corporation
Interactive
Panel
|
Innovator or Fast
Follower? Creating a Model that Best
Positions Your Organization to Increase Profitability
Panelists:
Gianni Gromo, M.D., Ph.D. , Head of
Discovery Research Basel,
F. Hoffmann-La Roche Ltd.
James Resch, Ph.D., Director, Strategic Planning, Drug
Discovery,
AstraZeneca
Daniel Schirlin, Ph.D., Head of Global Lead Generation, Aventis
Ramana Sonty, Senior Director/Team Leader World Wide
Development,
Pfizer Global Pharmaceuticals
|
Creating A Productive
R&D Organization
The Unconventional Mindset: A Case Study in Mitigating
R&D 'Decision Risk'
Thomas Unger, Ph.D., Vice
President - Life Sciences, Wood Mackenzie
Creating
an Organizational Culture That Breeds Productivity
Kevin
Koch, Ph.D., President and Chief Scientific Officer, Array BioPharma
Creating
Drug Hunters: Increasing an Individual Scientist's Productivity
Andrew
Hopkins, Ph.D., Senior Principal Scientist, Molecular Informatics,
Pfizer
Global Research and Development
R&D
Fiscal Responsibility
A Challenging
Strategy: Going Beyond Scenario-based Planning
into Predictive Mode
James
Resch, Ph.D., Director, Strategic Planning, Drug Discovery,
AstraZeneca
Profiting from Discovery and Marketing
Collaboration
Matthew Bell, Ph.D.,
Director, Discovery Research Strategy,
Wyeth Pharmaceuticals
Evaluating Outsourcing Options in Drug Discovery -
Balancing R&D
Opportunities with External Partnerships
Ron Newbold, Ph.D., Senior Director, Strategic
Research Initiatives,
External Scientific Affairs, Merck & Co
For
More Information on this Event Visit:
www.chi-intelligentdrug.com
|